RDGT · Ridgetech Inc.
Market Cap
$3.63M
Shares
3.63M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$132.16M
+10.2%
FY2026
Net Income
-$1.25M
-112.3%
FY2026
Gross Margin
3.6%
+0.4pp
FY2026
Operating Margin
-1.41%
-0.6pp
FY2026
Diluted EPS
-$17.21
-106.2%
FY2026
Operating Cash Flow
-$1.39M
-211.7%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $132.16M | $119.97M | $123.99M | $120.2M | $164.39M | $133.13M | $117.33M | |
| — | — | $516.64K | $883.91K | $401.92K | $707.88K | — | |
| $127.41M | $116.13M | $119.12M | $148.81M | $164.39M | $133.13M | $91.8M | |
| $4.75M | $3.84M | $4.88M | $3.6M | $36.52M | $29.24M | $25.53M | |
| 3.6% | 3.2% | 3.93% | 3% | 22.21% | 21.97% | 21.76% | |
| $3.58M | $3.34M | $3.35M | $5.14M | $8.19M | $6.96M | $8.11M | |
| $359.67K | $54.79K | $55.16K | $92.26K | $108.29K | $296.41K | — | |
| $363.69K | $1.14M | $790.45K | $718K | $1.26M | $1.75M | $2.08M | |
| — | — | — | — | $148.8K | — | — | |
| $6.62M | $4.87M | $4.28M | $16.76M | $39.21M | $38.08M | $32.53M | |
| -$1.87M | -$1.04M | $596.08K | -$13.16M | -$2.69M | -$8.84M | -$7M | |
| -1.41% | -0.86% | 0.48% | -10.95% | -1.64% | -6.64% | -5.97% | |
| -$1.5M | $101.9K | $1.39M | -$12.44M | -$1.44M | -$7.09M | -$4.92M | |
| $67.07K | -$92.83K | -$197.76K | -$31.58K | $262.22K | $455.19K | $698.52K | |
| $455.06K | $92.83K | $197.76K | — | — | — | — | |
| $516.5K | $84.68K | -$1.42M | $92.36K | $455.55K | $176.52K | -$204.06K | |
| — | — | -$1.61M | -$2.4M | — | — | — | |
| -$1.35M | -$950.66K | -$827.07K | -$15.44M | -$2.1M | -$8.34M | -$6.44M | |
| -$99.1K | $503.52K | -$41.36K | $394.54K | $1.1M | $31.64K | $16.26K | |
| -$1.25M | $10.19M | -$4.23M | -$21.14M | -$3.19M | -$8.12M | -$5.81M | |
| -0.95% | 8.5% | -3.41% | -17.59% | -1.94% | -6.1% | -4.95% | |
| — | $5384 | -$14 | -$252 | -$6247 | -$255.72K | — | |
| $257K | $8.99M | -$4.96M | -$23.76M | -$1.66M | -$7M | -$7.53M | |
| USD/shares | -$17.21 | $275.87 | -$439.78 | -$6,219.00 | -$2,752.50 | -$7,170.00 | -$6,480.00 |
| USD/shares | -$17.21 | $275.87 | -$439.78 | -$6,219.00 | -$2,752.50 | -$7,170.00 | -$6,480.00 |
| shares | 72.67K | 36.95K | 9628 | 3398.8533 | 1159.7733 | 1132.799 | 911.5713 |
| shares | 72.67K | 36.95K | 9628 | 3398.8533 | 1159.7733 | 1132.799 | 911.5713 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Offline Wholesale | $117,872,139 | $118,864,443 | $123,994,053 | — | — | — | — |
| Online Platform | $14,291,595 | $1,107,195 | — | — | — | — | — |
| Drug Wholesale | — | — | — | — | $49,944,699 | $34,549,739 | $29,705,237 |
| Offline Wholesale | — | — | — | $120,199,193 | — | — | — |
| Online Pharmacy | — | — | — | — | $30,219,364 | $22,485,919 | $13,541,215 |
| Retail Drugstores | — | — | — | — | $84,228,492 | $76,098,975 | $74,081,237 |
| Wholesale | — | — | — | — | $49,944,699 | $34,549,739 | $29,705,237 |
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue from Offline Wholesale | $117,872,139 | $118,864,443 | $123,994,053 | — | — | — |
| Revenue from Online Platform | $14,291,595 | $1,107,195 | — | — | — | — |
| Medical Devices | — | — | — | — | $7,647,035 | $9,934,604 |
| Nutritional Supplements | — | — | — | — | $12,526,502 | $8,122,886 |
| OTC Drugs | — | — | — | — | $62,939,689 | $50,568,902 |
| Prescription Drugs | — | — | — | — | $121,068,917 | $90,360,241 |
| Revenue from Offline Wholesale | — | — | — | $120,199,193 | — | — |
| Sundry Products | — | — | — | — | $4,002,324 | $3,403,845 |
| TCM | — | — | — | — | $6,152,787 | $5,293,894 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Online Platform | $270,810 | $45,326 | — | — | — | — | — |
| Offline Wholesale | -$2,136,825 | -$1,080,665 | $596,082 | — | — | — | — |
| Drug Wholesale | — | — | — | — | $3,129,020 | $202,699 | -$1,315,035 |
| Herbs Farming | — | — | — | — | — | -$261,790 | — |
| Offline Wholesale | — | — | — | -$13,162,324 | — | — | — |
| Online Pharmacy | — | — | — | — | -$659,477 | -$720,698 | -$957,287 |
| Retail Drugstores | — | — | — | — | -$5,163,433 | -$8,057,451 | -$4,731,420 |
Operating Margin by Segment (%)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Offline Wholesale | -1.8% | -0.9% | 0.5% | — | — | — | — |
| Online Platform | 1.9% | 4.1% | — | — | — | — | — |
| Drug Wholesale | — | — | — | — | 6.3% | 0.6% | -4.4% |
| Offline Wholesale | — | — | — | -11% | — | — | — |
| Online Pharmacy | — | — | — | — | -2.2% | -3.2% | -7.1% |
| Retail Drugstores | — | — | — | — | -6.1% | -10.6% | -6.4% |